Welcome to our dedicated page for American Well news (Ticker: AMWL), a resource for investors and traders seeking the latest updates and insights on American Well stock.
American Well Corporation reports developments for Amwell, a SaaS-based software platform for technology-enabled healthcare used by payers and health systems. Company updates center on quarterly and annual operating results, business reviews, investor conference participation, and equity-compensation actions such as inducement-plan grants.
The Amwell platform combines software and services that support virtual care programs across the care continuum, including virtual primary care, urgent care, clinical partner programs, scheduling, provider workflows, prescribing, and treatment-guideline reference tools. News about AMWL commonly connects these platform capabilities with payer and health system relationships, partner clinical programs, and management commentary on technology-enabled care delivery.
Amwell (NYSE: AMWL) reported Q2 2026 revenue of $52.0 million, at the top of its guidance range, including $25.7 million in subscription revenue and $24.4 million from Amwell Medical Group visits. Gross margin was 53%. Net loss was ($9.6) million, improving from ($10.3) million in Q1 2026, while adjusted EBITDA was ($1.2) million versus ($3.1) million in Q1. Total platform visits were 0.8 million.
For 2026, Amwell raised the low end of its revenue outlook to $200–$205 million (from $195–$205 million) and improved adjusted EBITDA guidance to ($9)–($7) million (from ($16)–($12) million), reaffirmed AMG visit guidance of 1.32–1.37 million, and reiterated its goal of positive operating cash flow in Q4 2026. The company ended June 30, 2026 with $196.7 million in cash, cash equivalents and restricted cash and reported no debt.
Amwell (NYSE: AMWL) announced it will report its second quarter 2026 operating results after market close on Tuesday, August 4. Management will host a live conference call and webcast at 5 p.m. ET to review results and provide a general business update.
The live audio webcast will be available in the Investors section of Amwell's website, with a replay accessible at investors.amwell.com for about 90 days. Amwell describes its business as offering a comprehensive SaaS-based, technology-enabled care platform used by payers and health systems to support diverse clinical programs and online care access.
Amwell (NYSE: AMWL) reported results from a large, NIMH-funded randomized trial of its SilverCloud digital behavioral health platform, published in Nature Human Behaviour. The study followed 6,205 at-risk college students over two years across 26 U.S. campuses.
Students offered SilverCloud showed 74.4% participation versus 30.2% with traditional behavioral health pathways and had 4.3% lower prevalence of any measured mental disorder at six weeks, 4.9% at six months, and 3.8% at two years. According to Amwell, this difference could correspond to about $1.18 million in avoided mental health–related costs within the study sample.
Amwell (NYSE:AMWL) announced that CFO and COO Mark Hirschhorn will participate in the 21st Annual Needham Technology, Media & Consumer Conference, held virtually on May 14, 2026, including a fireside chat at 2:15 p.m. ET. An audio webcast will be available at investors.amwell.com.
Amwell (NYSE: AMWL) announced financial results for the first quarter ended March 31, 2026, and will host a conference call today at 5:00 p.m. ET. The earnings report and a live audio webcast are available at the company's investor site; a replay will be available for about 90 days.
Amwell (NYSE: AMWL) will report first quarter 2026 operating results after market close on Tuesday, May 5, 2026. The management team will host a live conference call and webcast at 5:00 p.m. ET to review the results and provide a business update.
The full earnings report and live audio webcast will be available in the Investors section of the company's website, with a webcast replay accessible at investors.amwell.com for approximately 90 days.
Amwell (NYSE: AMWL) said CFO and COO Mark Hirschhorn will participate in the TD Cowen 46th Annual Health Care Conference in Boston on March 3, 2026, including a fireside chat at 3:10 p.m. ET.
An audio webcast of the fireside chat will be available at the company investor website.
Amwell (NYSE: AMWL) announced on February 18, 2026 a grant of 61,559 RSUs to one new employee as a material inducement to employment. The grant was approved by the Compensation Committee under Amwell’s Inducement Plan and relies on the NYSE employment inducement exemption.
The RSUs vest 25% on the first anniversary of the grant, with the remaining 75% vesting in equal pro rata increments every three months thereafter over three years (beginning the first calendar day of the month after the three-month period following the Initial Vesting Date).
Amwell (NYSE: AMWL) announced fourth-quarter and full-year 2025 financial results and will host a conference call today, Feb 12, 2026, at 5:00 p.m. ET.
The company said investors can view the earnings release and access a live audio webcast at the provided link; a replay will be available for ~90 days on the investor site.
Amwell (NYSE: AMWL) will report fourth quarter and full year 2025 operating results after market close on Thursday, Feb. 12, 2026. Management will host a live conference call and webcast at 5:00 p.m. ET to review results and provide a business update.
The full earnings release and live audio webcast will be available in the company's Investors section; a webcast replay will remain available at investors.amwell.com for approximately 90 days.